Rising Demand for Hospital Injectable Drugs Market Key Players, Growth Analysis during 2021-2027
The global hospital injectable drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market growth include the rising demand for biologics, rising prevalence of chronic diseases, and the benefits of injectables (convenience, ease of use, and reduced pain). These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors, which in turn, is expected to boost the growth of the market. Moreover, as biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to accelerate the market growth in the coming years.
To Request a Sample of our Report on Hospital Injectable
Drugs Market: https://www.omrglobal.com/request-sample/hospital-injectable-drugs-market
Over the years, the use of
injectable contraceptives has increased significantly. This increased use of
injectable contraceptives can mainly be attributed owing to their high
efficacy. Injectable contraceptives are not required to be taken daily; they
can be administered once every month or once every three months and are
considered to be one of the safer modes of pregnancy prevention. They prevent
pregnancy 99% of the time, when administered correctly. Owing to these reasons,
the demand for contraceptive injectables is expected to drive the market in the
future. Furthermore, new launches have been witnessed in the market. For
instance, in December 2021, the US FDA approved GSK’s Apretude, or
cabotegravir, to reduce the risk of sexually acquired HIV. The endorsement
provides users the first long-acting injected option in the pre-exposure
prophylaxis (PrEP) setting. With this approval, Apretude will go up against
Gilead’s well-established Truvada and its generic, plus the California
biotech’s newer Descovy.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
Gilead Sciences, Inc., GlaxoSmithKline plc, and Baxter International Inc.,
among others.
(Get 15% Discount on Buying this Report)
A
full Report of Hospital Injectable Drugs Market is Available @ https://www.omrglobal.com/industry-reports/hospital-injectable-drugs-market
Global Hospital Injectable Drugs Market Report by Segment
By Application
·
Cardiology and Metabolic Disorders,
·
Oncology
·
Neurology
·
Gastroenterology
·
Pain
·
Infectious Diseases
·
Others
By Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
E-Commerce
Global Hospital Injectable Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment